Theralase Technologies (TSXV:TLT) Days Inventory : 375.70 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Theralase Technologies's Average Total Inventories for the three months ended in Dec. 2023 was C$0.60 Mil. Theralase Technologies's Cost of Goods Sold for the three months ended in Dec. 2023 was C$0.15 Mil. Hence, Theralase Technologies's Days Inventory for the three months ended in Dec. 2023 was 375.70.

The historical rank and industry rank for Theralase Technologies's Days Inventory or its related term are showing as below:

TSXV:TLT' s Days Inventory Range Over the Past 10 Years
Min: 192.82 Med: 385.08 Max: 516.55
Current: 516.55

During the past 13 years, Theralase Technologies's highest Days Inventory was 516.55. The lowest was 192.82. And the median was 385.08.

TSXV:TLT's Days Inventory is ranked worse than
87.52% of 777 companies
in the Medical Devices & Instruments industry
Industry Median: 193.31 vs TSXV:TLT: 516.55

Theralase Technologies's Days Inventory increased from Sep. 2022 (346.83) to Dec. 2023 (375.70). It might indicate that Theralase Technologies's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Theralase Technologies's Inventory Turnover for the three months ended in Dec. 2023 was 0.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Theralase Technologies's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.64.

Theralase Technologies Days Inventory Historical Data

The historical data trend for Theralase Technologies's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Days Inventory Chart

Theralase Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

320.74

325.40

394.45

375.71

410.98

Theralase Technologies Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															346.83	340.69	423.83	364.02	375.70

Competitive Comparison of Theralase Technologies's Days Inventory

For the Medical Devices subindustry, Theralase Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralase Technologies's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Days Inventory distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Days Inventory falls into.

Theralase Technologies Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Theralase Technologies's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.486	+	0.658)	/	2 )	/	0.508	*	365
=	0.572					/	0.508	*	365
=	410.98

Theralase Technologies's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.536	+	0.658)	/	2 )	/	0.145	*	365 / 4
=	0.597					/	0.145	*	365 / 4
=	375.70

Theralase Technologies (TSXV:TLT) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Theralase Technologies's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.145	/	0.597
	=	0.24

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Theralase Technologies's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.597	/	0.364
	=	1.64

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Theralase Technologies Days Inventory Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies (TSXV:TLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

TLTFF:USA

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Executives

Matthew Thomas Perraton

Director